Aluminium Phosphate, Haemophilus Influenzae Type B Capsular Polysaccharide, Thiomersal

Aluminium Phosphate, Haemophilus Influenzae Type B Capsular Polysaccharide, and Thiomersal are components of a combination vaccine. This vaccine is designed to protect against Haemophilus influenzae type b (Hib), a bacterium that can cause severe infections in young children, such as meningitis, pneumonia, and epiglottitis.
Aluminium Phosphate is an adjuvant, which helps to stimulate the immune system and enhance the body’s response to the vaccine. Haemophilus Influenzae Type B Capsular Polysaccharide is the antigen that specifically targets the Hib bacterium, triggering the production of antibodies to fight the infection. Thiomersal is a preservative that helps maintain the vaccine’s sterility and stability.
This combination vaccine is typically administered to infants and young children as part of their routine immunization schedule. By receiving the vaccine, children are protected against Hib infections, which can be life-threatening if left untreated. The vaccine is an essential tool in the prevention of Hib-related diseases and contributes to the overall health and well-being of children.